HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,258 | -87.1% | 46 | -91.2% | 0.00% | – |
| Q1 2023 | $9,760 | +74976.9% | 525 | +4.2% | 0.00% | – |
| Q4 2022 | $13 | -100.0% | 504 | -70.6% | 0.00% | -100.0% |
| Q3 2022 | $38,000 | +111.1% | 1,717 | +87.9% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | -5.3% | 914 | -3.0% | 0.00% | – |
| Q1 2022 | $19,000 | +1800.0% | 942 | +3264.3% | 0.00% | – |
| Q4 2021 | $1,000 | -98.7% | 28 | -98.5% | 0.00% | -100.0% |
| Q3 2021 | $78,000 | -11.4% | 1,865 | -3.0% | 0.00% | 0.0% |
| Q2 2021 | $88,000 | -28.5% | 1,922 | -34.7% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +23.0% | 2,942 | +26.6% | 0.00% | -50.0% |
| Q4 2020 | $100,000 | – | 2,324 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $132,000 | -35.6% | 9,225 | -18.4% | 0.01% | 0.0% |
| Q3 2018 | $205,000 | +9.6% | 11,300 | +2.0% | 0.01% | 0.0% |
| Q2 2018 | $187,000 | -31.0% | 11,075 | -17.2% | 0.01% | -33.3% |
| Q1 2018 | $271,000 | 0.0% | 13,375 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $271,000 | +34.2% | 13,375 | +14.9% | 0.01% | +50.0% |
| Q3 2017 | $202,000 | +7.4% | 11,636 | -20.8% | 0.01% | 0.0% |
| Q2 2017 | $188,000 | +0.5% | 14,686 | +1.6% | 0.01% | -11.1% |
| Q1 2017 | $187,000 | +78.1% | 14,460 | +36.3% | 0.01% | +80.0% |
| Q4 2016 | $105,000 | -4.5% | 10,610 | +16.5% | 0.01% | -16.7% |
| Q3 2016 | $110,000 | +14.6% | 9,111 | -17.7% | 0.01% | +20.0% |
| Q2 2016 | $96,000 | +95.9% | 11,077 | +290.6% | 0.01% | +66.7% |
| Q4 2015 | $49,000 | – | 2,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |